189 related articles for article (PubMed ID: 31168625)
1. Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause.
Lee SR; Lee YH; Yang H; Lee HW; Lee GS; An BS; Jeung EB; Park BK; Hong EJ
Carcinogenesis; 2019 Aug; 40(8):1031-1041. PubMed ID: 31168625
[TBL] [Abstract][Full Text] [Related]
2. Dietary Intake of 17α-Ethinylestradiol Promotes HCC Progression in Humanized Male Mice Expressing Sex Hormone-Binding Globulin.
Lee SR; Jeong SH; Heo JH; Jo SL; Ko JW; Kwun HJ; Hong EJ
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830439
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma.
Casagrande V; Mauriello A; Bischetti S; Mavilio M; Federici M; Menghini R
Sci Rep; 2017 Jul; 7(1):6747. PubMed ID: 28751722
[TBL] [Abstract][Full Text] [Related]
5. Sex Hormone-Binding Globulin Expression Correlates With Acetyl-Coenzyme A Carboxylase and Triglyceride Content in Human Liver.
Sáez-López C; Salcedo-Allende MT; Hernandez C; Simó-Servat O; Simó R; Selva DM
J Clin Endocrinol Metab; 2019 May; 104(5):1500-1507. PubMed ID: 30496542
[TBL] [Abstract][Full Text] [Related]
6. MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model.
Sakamoto H; Miyanishi K; Tanaka S; Ito R; Hamaguchi K; Sakurada A; Sato M; Kubo T; Osuga T; Murase K; Takada K; Nakabeppu Y; Kobune M; Kato J
Sci Rep; 2021 Feb; 11(1):3599. PubMed ID: 33574380
[TBL] [Abstract][Full Text] [Related]
7. Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease.
Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
Lipids Health Dis; 2020 Dec; 19(1):250. PubMed ID: 33298075
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
10. Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development.
Saez-Lopez C; Barbosa-Desongles A; Hernandez C; Dyer RA; Innis SM; Simó R; Selva DM
Endocrinology; 2017 Mar; 158(3):545-559. PubMed ID: 28359088
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
12. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
[TBL] [Abstract][Full Text] [Related]
13. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
15. A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet.
Motiño O; Li S; Lambertucci F; Anagnostopoulos G; Montégut L; Nogueira-Recalde U; Chen H; Maiuri MC; Kroemer G; Martins I
Methods Mol Biol; 2024; 2769():67-75. PubMed ID: 38315389
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.
Nelson ME; Lahiri S; Chow JD; Byrne FL; Hargett SR; Breen DS; Olzomer EM; Wu LE; Cooney GJ; Turner N; James DE; Slack-Davis JK; Lackner C; Caldwell SH; Hoehn KL
Nat Commun; 2017 Mar; 8():14689. PubMed ID: 28290443
[TBL] [Abstract][Full Text] [Related]
18. miR-21-5p promotes NASH-related hepatocarcinogenesis.
Rodrigues PM; Afonso MB; Simão AL; Islam T; Gaspar MM; O'Rourke CJ; Lewinska M; Andersen JB; Arretxe E; Alonso C; Santos-Laso Á; Izquierdo-Sanchez L; Jimenez-Agüero R; Eizaguirre E; Bujanda L; Pareja MJ; Prip-Buus C; Banales JM; Rodrigues CMP; Castro RE
Liver Int; 2023 Oct; 43(10):2256-2274. PubMed ID: 37534739
[TBL] [Abstract][Full Text] [Related]
19. Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease.
Assante G; Chandrasekaran S; Ng S; Tourna A; Chung CH; Isse KA; Banks JL; Soffientini U; Filippi C; Dhawan A; Liu M; Rozen SG; Hoare M; Campbell P; Ballard JWO; Turner N; Morris MJ; Chokshi S; Youngson NA
Genome Med; 2022 Jun; 14(1):67. PubMed ID: 35739588
[TBL] [Abstract][Full Text] [Related]
20. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
